Abbott Diabetes Care History
Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In April 2004, Abbott announced it had completed the acquisition of TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results, Virtually Pain-Free. The TheraSense acquisition strengthened Abbott's position in the large and growing blood glucose monitoring market.
|Abbott Diabetes Care Canada, Inc.
|Customer Support: 1 (888) 519-6890|
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.
In Canada, Abbott has approximately 1,500 employees working in manufacturing, distribution and logistics, as well as sales and marketing. Primary locations in Canada are in Montreal, Markham, Mississauga, Brockville, Ottawa, Victoriaville and Edmonton.
For more information about Abbott, please visit:
For more information about Abbott Diabetes Care, visit www.abbottdiabetescare.com
For more information on Abbott Canada, visit www.abbott.ca
For more information on Abbott, including lines of business and products, visit www.abbott.com